PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
Healthcare Improvement Scotland
Record ID 32013000491
English
Authors' objectives:
1. What is the relative clinical and cost effectiveness of PET/CT compared to alternate diagnostic imaging modalities in the investigation of PNS?
2. Assuming diagnosis using PET/CT is clinically and cost effective, at what stage should it be used in the diagnostic pathway?
Authors' recommendations:
Overall, although many of the studies included within this scoping report conclude that PET/CT offers some advantages in the diagnosis of PNS, the evidence to support a response to the scoping report questions is of low quality. The six cohort studies and four case series studies identified had small sample sizes and many were retrospective. The study objectives tended to focus on the usefulness of using PET/CT subsequent to the
use of other imaging techniques, rather than a direct comparison between PET/CT and other diagnostic imaging modalities. Interpretation of the evidence was made additionally challenging owing to the fact that, across the studies, PET/CT was used in a variety of different stages within the patients' diagnostic pathway
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/shtg_scoping_reports/technologies_scoping_report_19.aspx
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Humans
- Critical Pathways
- Sensitivity and Specificity
- Paraneoplastic Syndromes
Contact
Organisation Name:
Scottish Health Technologies Group
Contact Address:
Scottish Health Technologies Group, Delta House, 50 West Nile Street, Glasgow, G1 2NP Tel: 0141 225 6998
Contact Name:
his.shtg@nhs.scot
Contact Email:
his.shtg@nhs.scot
Copyright:
Healthcare Improvement Scotland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.